Form 4: Procter & Gamble Director Ashley McEvoy Reports Acquisition of Common Stock
SEC Form 4 Filing
Director Ashley McEvoy reports acquiring 145 shares of Procter & Gamble common stock on March 11, 2025, through the company's 2019 Stock and Incentive Compensation Plan.
Summary
- Ashley McEvoy, a director at Procter & Gamble, filed a Form 4 indicating a change in beneficial ownership of the company's stock.
- On March 11, 2025, McEvoy acquired 145 shares of common stock.
- The acquisition was made under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
- The price per share for the acquisition was $0.
- Following the transaction, McEvoy's total beneficial ownership of Procter & Gamble common stock is 3,433.9488 shares, which includes dividend equivalents in the form of Restricted Stock Units.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares suggests confidence in the company, but it's a routine transaction.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's continued investment in the company.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it signals insider confidence.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of transaction: Ashley McEvoy acquired 145 shares of common stock. |
| 03/12/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.